Navigation Links
CSA Medical Appoints Wendelin Maners VP of Emerging Therapies

BALTIMORE, Sept. 12, 2011 /PRNewswire/ -- CSA Medical, Inc. (, the leading developer of novel Spray Cryotherapy devices that flash freeze and treat diseased tissue inside the body, today announced the appointment of Wendelin Maners to the newly created position of Vice President, Emerging Therapies. In this role Maners will be responsible for the development of new therapeutic applications for the company's Spray Cryotherapy technology.

"Wendelin has an impressive track record of working closely with executive teams and applying a thoughtful, analytical and collaborative approach to building new markets and solidifying current platforms," said Bill Floyd, CEO and president of CSA Medical. "Throughout her career she has also executed over $3 billion in transactions that provided product and therapy diversification to maximize shareholder value. We are thrilled to have her join our team."

Maners brings to CSA Medical more than 18 years of global medical device experience focused on acquisition, licensing and marketing emerging technologies. Most recently she served as Vice President, Strategy and Business Development at Boston Scientific Corporation where she developed and executed acquisition and investment strategies in the Neuromodulation and Electrophysiology markets, as well as new markets for the company. During her tenure at Boston Scientific, Maners' focus also included entering the implantable microelectronics space with the acquisition of Advanced Bionics and leading the due diligence and negotiations for the acquisition of CryoCor, an endocardial cryo ablation technology for atrial fibrillation. From 2000-2003, Ms. Maners worked as an investment banker with Barrington Associates (Wells Fargo Securities). Previously she held marketing positions focused on entering new markets with Boston Scientific's urology and interventional neuroradiology divisions. Maners holds a bachelor of science degree in Business Administration from the University of Southern California Marshall School of Business.

"I believe that CSA Medical's Spray Cryotherapy device has tremendous potential to treat multiple disease states, drastically improve patient outcomes and reduce the cost of healthcare," said Maners. "I look forward to working with my colleagues to realize the fullest potential for this innovative technology."

About CSA Medical

CSA Medical, Inc. develops and manufactures a proprietary therapeutic interventional platform, the Spray Cryotherapy System, comprised of a device, specialty catheters and agent that allows delivery of therapeutic doses of a cryogen to flash freeze and destroy diseased tissue inside the body. The Company is the first to harness the power of extreme cold (-196 C) liquid nitrogen therapeutic energy delivery inside the body. To learn more, please visit

SOURCE CSA Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... Research and Markets has announced the ... 2016 - Forecast to 2022" report to their offering. ... up to date financial data derived from varied research sources ... with potential impact on the market during the next five ... comprises of sub markets, regional and country level analysis. The ...
(Date:6/23/2016)... June 23, 2016 , , ... July 7, 2016 , , , , LOCATION: , , ... , , , EXPERT PANELISTS:  , , , Frost & ... Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, ... The global pharmaceutical industry is witnessing an exceptional era. Several new ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
Breaking Medicine News(10 mins):